APA-referens

Wei, Y., Liao, S., Wang, S., Wang, C., & Yang, C. (2021). Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways. Front Endocrinol (Lausanne).

Chicago-stil citat

Wei, Yi-Hsuan, Shu-Lang Liao, Sen-Hsu Wang, Chia-Chun Wang, och Chang-Hao Yang. "Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts Via RhoA-Mediated ERK and P38 Signaling Pathways." Front Endocrinol (Lausanne) 2021.

MLA-referens

Wei, Yi-Hsuan, et al. "Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts Via RhoA-Mediated ERK and P38 Signaling Pathways." Front Endocrinol (Lausanne) 2021.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.